The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Barrett’s Esophagus Common in Women with Scleroderma

Barrett’s Esophagus Common in Women with Scleroderma

January 21, 2021 • By Reuters Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—Barrett’s esophagus is common in women with systemic sclerosis or scleroderma (SSc) and is often accompanied by dysplasia, according to the largest study on prevalence of Barrett’s esophagus in women with SSc. In Barrett’s esophagus, chronic gastric reflux causes the lining the esophagus to be replaced by metaplastic cells that may lead to adenocarcinoma.

You Might Also Like
  • Studies Show Promise for Scleroderma Therapy and Prediction of Progressing Disease
  • Treatments for Scleroderma with Gastrointestinal Involvement Address Symptoms
  • Pain Perspective in Scleroderma

Among 235 women with SSc who underwent esophagogastroduodenoscopy, 30 had histologically proven Barrett’s esophagus, yielding a prevalence of 13%, researchers from Mayo Clinic, Scottsdale, Ariz., report in the American Journal of Gastroenterology.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Patients with SSc with Barrett’s esophagus (vs. without) were significantly older (64 vs. 58 years) and more often had the limited type of SSc (87% vs. 68%), Francisco C. Ramirez, MD, and colleagues note.

Women with SSc and Barrett’s esophagus were also significantly more likely to have absent contractility with hypotensive lower esophageal sphincter findings on high-resolution manometry, suggesting greater predisposition to gastroesophageal reflux disease (GERD), they say. All of the women with SSc and Barrett’s esophagus had GERD symptoms as did 92% of women with SSc without Barrett’s esophagus.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Of note, say the researchers, 13 (43%) of the 30 women with SSc and Barrett’s esophagus had dysplasia, including four (12%) with indefinite dysplasia, seven (21%) with low-grade dysplasia and two (6%) with esophageal adenocarcinoma.

“The prevalence of any dysplasia including esophageal adenocarcinoma was estimated to be 43% and a calculated incidence of 5.3% per year (0.9% per year for adenocarcinoma),” the researchers note in their article.

It’s well-known that dysplastic Barrett’s esophagus is the best predictor for progression into esophageal adenocarcinoma, they point out. “These data suggest that women with SSc should be included in the screening recommendations for Barrett’s esophagus and treated accordingly if dysplasia is found,” they conclude.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The study had no financial support and the authors have declared no competing interests.


Reference

  1. Snyder DL, Crowell MD, Kahn A, et al. Prevalence of Barrett’s esophagus in female patients with scleroderma. Am J Gastroenterol. 2021 Jan 7. Online ahead of print.

Filed Under: Conditions, Scleroderma Tagged With: adenocarcinoma, Barrett's esophagus, Scleroderma, Systemic sclerosis, systemic sclerosis (SSc), Women

You Might Also Like:
  • Studies Show Promise for Scleroderma Therapy and Prediction of Progressing Disease
  • Treatments for Scleroderma with Gastrointestinal Involvement Address Symptoms
  • Pain Perspective in Scleroderma
  • Targeted Therapy for Scleroderma Fibrosis

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.